Laidlaw Wealth Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,500
Closed -$85K 216
2020
Q2
$85K Buy
+10,500
New +$85K 0.04% 176